The Claim

Dark roast coffee extracts inhibit amyloid-beta oligomerization more potently than light roast coffee extracts, with an IC50 of approximately 9.5 μg/mL versus 40.3 μg/mL, suggesting that roasting intensity enhances the anti-aggregation activity of coffee through formation of phenylindanes.

Source: Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Dark roast coffee seems to stop harmful clumps in the brain better than light roast coffee, and scientists think it’s because the darker roasting creates special compounds called phenylindanes.

See the scientific wording

Dark roast coffee extracts inhibit amyloid-beta oligomerization more potently than light roast coffee extracts, with an IC50 of approximately 9.5 μg/mL versus 40.3 μg/mL, suggesting that roasting intensity enhances the anti-aggregation activity of coffee through formation of phenylindanes.

What the research says

1 study
  1. Study: Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation

    Dark roast coffee has more of a special compound made during roasting that stops harmful brain clumps better than light roast, and the study proves it.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.